DOCSLIB.ORG

Confluent and Reticulated Papillomatosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Confluent and Reticulated Papillomatosis Journal of the American Osteopathic College of Dermatology Journal of the American Osteopathic College of Dermatology 2009-2010 AOCD Officers President: Marc I. Epstein, D.O., FAOCD President-Elect: Leslie Kramer, D.O., FAOCD First Vice-President: Bradley P. Glick, D.O., FAOCD Second Vice-President: James B. Towry, D.O., FAOCD Third Vice-President: Karen E. Neubauer, D.O., FAOCD Secretary - Treasurer: Jere J. Mammino, D.O., FAOCD Immediate Past-President: Donald K. Tillman, Jr., D.O., FAOCD Trustees: David L. Grice, D.O., FAOCD Mark A. Kuriata, D.O., FAOCD Rick Lin, D.O., FAOCD Editors Suzanne Rozenberg, D.O., FAOCD Jay S. Gottlieb, DO Andrew Racette, D.O., FAOCD Jon Keeling, DO Celeste Angel, D.O., FAOCD Andrew Racette, DO Executive Director: Rebecca Mansfield Editorial Review Board Kevin Belasco, DO Sponsors: Rich Bernert, M.D. Global Pathology Laboratory JAOCD Iqbal Bukhari, MD Medicis Founding Sponsor Ryan Carlson, DO JAOCD Founding Sponsor Igor Chaplik, DO Galderma Michael Conroy, M.D. Ranbaxy Brad Glick, DO, FAOCD Melinda Greenfield, DO Andrew J Hanly, MD JAOCD David Horowitz, DO, FAOCD Founding Sponsor Matt Leavitt, DO, FAOCD AOCD • 1501 E. Illinois • Kirksville, MO 63501 Mark Lebwohl, MD 800-449-2623 • FAX: 660-627-2623 www.aocd.org Rick Lin, DO Megan Machuzak, D.O. COPYRIGHT AND PERMISSION: written permission must be obtained from the Journal of the American Osteopathic College of Dermatology Jere Mammino, DO, FAOCD for copying or reprinting text of more than half page, tables or figures. John Minni, DO Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgement of the original source, Navid Nami, DO and a payment of $15 per page, table or figure of reproduced material. Permission fees are waived for authors wishing to reproduce their own Shaheen Oshtory, DO articles. Request for permission should be directed to JAOCD c/o AOCD John Perrotto, DO PO Box 7525 Kirksville, MO 63501 Copyright 2003 by the Journal of the American Osteopathic College of Stephen Purcell, DO, FAOCD Dermatology Michael Scott, DO, FAOCD Printed by: The Dimensional Group, Mason City, IA 50401 Kevin Spohr, DO Proofreading: Julia Layton, Freelance Proofreading and Editing Journal of the American Osteopathic College of Dermatology VOLUME 18, NUMBER 1 NOVEMBER 2010 JOURNAL OF THE AMERICaocdAN OSTEOPATHIC COLLEGE OF DERMATOLOGY CONTENTS Letter from the JAOCD Editors .....................................................................................................................................................................4 Letter from the President ...............................................................................................................................................................................5 Aggressive Angiomyxoma: A Rare Perineal Tumor ......................................................................................................................................6 Angela Combs, D.O.,* Stanley Skopit, D.O., FAOCD** Confluent and Reticulated Papillomatosis ...................................................................................................................................................7 Robert A. Norman, DO, MPH, MBA,* Daniel R. Johnson, OMSIV** Minocycline-induced Hyperpigmentation in a Patient with Hidradenitis Suppurativa: A Case Report ..................................................9 Chris Buckley, D.O.,* Stanley Skopit, D.O., FAOCD** Lichen Aureus: A Case Report and Review of the Traditional, Nutritional, and Alternative Treatment Options ............................................................................................................................................................13 Raymond R. Knisley, D.O.,* Bruce F. McDonald, D.O., F.A.O.C.D.** Cholesterol Embolism Syndrome: A Case Report and Review of the Literature......................................................................................15 Laura DeStefano DO,* Janet Allenby DO** Acute Generalized Exanthematous Pustulosis: A Case Report and Review ..............................................................................................17 Joseph Del Priore, D.O.,* Michael Kassardjian, MSIV,** David Horowitz, D.O., F.A.O.C.D., F.A.A.D.*** Malignant Glomus Tumor: A Case Series and Review of the Literature ...................................................................................................21 Michael Kassardjian, B.A.,* Jack Griffith, D.O.,** Paul Shitabata, M.D.,*** David Horowitz, D.O., F.A.O.C.D., F.A.A.D.**** A Rare Morpheaform Complication of a Black Ink Tattoo .......................................................................................................................24 Scott Deckelbaum, DO,* Jack Griffith, DO,** Paul Shitabata, MD,*** Mark Horowitz, DO,**** David Horowitz, DO, FAOCD, FAAD***** Lessons in Dermatoscopy: Dermatoscopic Pattern of Facial Melanoma in Situ (Lentigo Maligna) .......................................................26 Theresa Cao, DO,1 Margaret Oliviero, ARNP,2 Stanley Skopit, DO, FAOCD,3 Harold Rabinovitz, MD, FAAD2 A Bump on a Child’s Foot: Infantile Digital Fibromatosis ........................................................................................................................28 Angela Combs, D.O.,* Stanley Skopit, D.O., FAOCD** A Case Report of Muir-Torre Syndrome ....................................................................................................................................................30 Theresa Cao, DO,1 Verena Ahlgrimm-Siess, MD,2 Margaret Oliviero, ARNP,3 Stanley E. Skopit, DO, FAOCD,4 Harold S. Rabinovitz, MD, FAAD5 Review of Stevens-Johnson Syndrome and Toxic Epidermal Necrosis: A Case Report and Discussion .................................................32 Roya Ghorsriz, D.O.,* Emily Rubenstein, D.O.,** Stanley Skopit, D.O., FAOCD,*** Tracy Favreau, D.O. FAOCD***** Removing a Gun Powder Tattoo From a Cannon Blast: A Unique Approach with Laser Therapy .........................................................37 Jonathan Crane, D.O., F.A.O.C.D., Ronald Benjamin, M.D., Patricia Hood, M.S.P.A.-C, Kelly Britt, M.S.P.A.-C, Charlene Snyder, M.S.P.A.-C., James A. Bailey, PhD Melanoma Epidemiology ............................................................................................................................................................................38 Megan Morrison, BS,* Daniel Hogan, MD,** Jarvis Tzeng, DO, PGY-3*** Erythema Dyschromicum Perstans: A Case Report and Review of the Literature ...................................................................................41 Rupa Reddy, DO,* Stanley Skopit, DO, FAOCD** Low-molecular-weight Heparin: A Novel Treatment Option for Ashy Dermatosis ................................................................................43 Magalys Vitiello, MD,* Alejandra Vivas, MD,** Andleeb Usmani, DO,*** Janet Allenby, DO, FAOCD,**** Francisco A. Kerdel, BSc, MBBS***** Cutaneous Larva Migrans: A Case Report and Discussion .......................................................................................................................45 Robert Levine, DO,* Suzanne Sirota-Rozenberg, DO, FAOCD,** Marvin S. Watsky, DO, FAOCD*** An Unusual Presentation of Antiphospholipid Syndrome ........................................................................................................................49 Shari Sperling, DO,* Suzanne Sirota-Rozenberg, DO,** Marvin S. Watsky, DO,*** Lewis Cuni, MD**** Extranodal Rosai-Dorfman Disease Presenting with Progressive Nasal Congestion ...............................................................................51 Brooke Renner, D.O.,* Lynn Sikorski, D.O.,** Annette LaCasse, D.O.*** Rheumatoid Neutrophilic Dermatitis ........................................................................................................................................................55 Leah M. Schammel, D.O.,* Steven K. Grekin, D.O., FAOCD** LETTER FROM THE EDITORS JAY GOTTLIEB, DO, JON KEELING, DO, ANDREW RACETTE, DO, FAOCD Senior Editor FAOCD Editor FAOCD Editor Help the JAOCD to grow… The JAOCD continues to improve with each issue. We thank all of the authors who have contributed articles. The use of Editorial Manager for submission, review, and editing has made it easier to produce a quality journal. The journal provides the unique opportunity for residents and dermatologists in our college to contribute to the dermatology literature and improve the status of our college through education. In order to achieve our goal of becoming an indexed publication and producing more issues annually, we need your help. Our reviewers do a fantastic job of helping to make each article the best and most complete it can be. A small group of reviewers is not enough to handle the large number of articles that are submitted. We are in desperate need of more reviewers. If you have just become a fellow of the AOCD, becoming a reviewer with the JAOCD is a great way to become involved in our college. It allows you to give back to the profession that has given so much to you. You will be listed as a member of the editorial review committee in each issue of the journal. Generally, you will be asked to review an article about once every three to four months. The review process is easy and is done completely online through Editorial Manager. Please contact us at [email protected] if you are willing to help us by becoming a reviewer. We encourage our fellow members, residents, and those applying for dermatology
Load more

Recommended publications
  • Concurrent Beau Lines, Onychomadesis, and Retronychia Following Scurvy
    CASE REPORT Concurrent Beau Lines, Onychomadesis, and Retronychia Following Scurvy Dayoung Ko, BS; Shari R. Lipner, MD, PhD the proximal nail plate from the distal nail plate leading to shedding of the nail. It occurs due to a complete growth PRACTICE POINTS arrest in the nail matrix and is thought to be on a con- • Beau lines, onychomadesis, and retronychia are nail tinuum with Beau lines. The etiologies of these 2 condi- conditions with distinct clinical findings. tions overlap and include trauma, inflammatory diseases, • Beau lines and onychomadesis may be seen 1-5 concurrently following trauma, inflammatory dis- systemic illnesses, hereditary conditions, and infections. eases, systemic illnesses, hereditary conditions, In almost all cases of both conditions, normal nail plate and infections. production ensues upon identification and removal of the 3,4,6 • Retronychia shares a common pathophysiology inciting agent or recuperation from the causal illness. with Beau lines and onychomadesis, and all reflect Beau lines will move distally as the nail grows out and slowing or cessation of nail plate production. can be clipped. In onychomadesis, the affected nails will be shed with time. Resolution of these nail defects can be estimated from average nail growth rates (1 mm/mo for fingernails and 2–3 mm/mo for toenails).7 Beau lines, onychomadesis, and retronychia are nail conditions with Retronychia is defined as a proximal ingrowing of their own characteristic clinical findings. It has been hypothesized the nail plate into the ventral surface of the proximal nail that these 3 disorders may share a common pathophysiologic fold.4,6 It is thought to occur via vertical progression of mechanism of slowing and/or halting nail plate production at the the nail plate into the proximal nail fold, repetitive nail nail matrix.
    [Show full text]
  • Review Cutaneous Patterns Are Often the Only Clue to a a R T I C L E Complex Underlying Vascular Pathology
    pp11 - 46 ABstract Review Cutaneous patterns are often the only clue to a A R T I C L E complex underlying vascular pathology. Reticulate pattern is probably one of the most important DERMATOLOGICAL dermatological signs of venous or arterial pathology involving the cutaneous microvasculature and its MANIFESTATIONS OF VENOUS presence may be the only sign of an important underlying pathology. Vascular malformations such DISEASE. PART II: Reticulate as cutis marmorata congenita telangiectasia, benign forms of livedo reticularis, and sinister conditions eruptions such as Sneddon’s syndrome can all present with a reticulate eruption. The literature dealing with this KUROSH PARSI MBBS, MSc (Med), FACP, FACD subject is confusing and full of inaccuracies. Terms Departments of Dermatology, St. Vincent’s Hospital & such as livedo reticularis, livedo racemosa, cutis Sydney Children’s Hospital, Sydney, Australia marmorata and retiform purpura have all been used to describe the same or entirely different conditions. To our knowledge, there are no published systematic reviews of reticulate eruptions in the medical Introduction literature. he reticulate pattern is probably one of the most This article is the second in a series of papers important dermatological signs that signifies the describing the dermatological manifestations of involvement of the underlying vascular networks venous disease. Given the wide scope of phlebology T and its overlap with many other specialties, this review and the cutaneous vasculature. It is seen in benign forms was divided into multiple instalments. We dedicated of livedo reticularis and in more sinister conditions such this instalment to demystifying the reticulate as Sneddon’s syndrome. There is considerable confusion pattern.
    [Show full text]
  • Truncal Rashes Stan L
    Healthy Baby Practical advice for treating newborns and toddlers. Getting Truculent with Truncal Rashes Stan L. Block, MD, FAAP A B C All images courtesy of Stan L. Block, MD, FAAP. Figure 1. Afebrile 22-month-old white male presents to your office with this slowly spreading, somewhat generalized, and refractory truncal rash for the past 4 weeks. It initially started on the right side of his trunk (A) and later extended down his right upper thigh (B). The rash has now spread to the contralateral side on his back (C), and is most confluent and thickest over his right lateral ribs. n a daily basis, we pediatricians would not be readily able to identify this rash initially began on the right side of his encounter a multitude of rashes relatively newly described truncal rash trunk (see Figure 1A) and then extended O of varied appearance in children shown in some of the following cases. distally down to his right upper thigh (see of all ages. Most of us gently-seasoned As is typical, certain clues are critical, Figure 1B). Although the rash is now dis- clinicians have seen nearly all versions including the child’s age, the duration tributed over most of his back (see Figure of these “typical” rashes. Yet, I venture and the distribution of the rash. Several 1C), it is most confluent and most dense to guess that many practitioners, who of these rashes notably mimic more com- over his right lateral ribs. would be in good company with some of mon etiologies, as discussed in some of From Figure 1, you could speculate my quite erudite partners (whom I asked), the following cases.
    [Show full text]
  • Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
    toxins Review Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Emanuela Martina †, Federico Diotallevi †, Giulia Radi †, Anna Campanati * and Annamaria Offidani Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60020 Ancona, Italy; [email protected] (E.M.); [email protected] (F.D.); [email protected] (G.R.); annamaria.offi[email protected] (A.O.) * Correspondence: [email protected] † These authors equally contributed to the manuscript. Abstract: Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis. Recently, botulinum toxins have also been used in many other skin diseases, in off label regimen. The objective of this manuscript is to review and analyze the main therapeutic applications of botulinum toxins in skin diseases. A systematic review of the published data was conducted, following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Botulinum toxins present several label and off-label indications of interest for dermatologists. The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey–Hailey disease, epidermolysis bullosa simplex Weber–Cockayne type, Darier’s disease, pachyonychia congenita, aquagenic keratoderma, alopecia, psoriasis, notalgia paresthetica, facial erythema and flushing, and oily skin.
    [Show full text]
  • Presented: February 2, 2017 Thru February 4, 2017
    2017 ACP Colorado Chapter Meeting February 2, 2017 thru February 4,2017 Broadmoor Hotel, Colorado Springs, Colorado Resident Abstracts Presented: February 2, 2017 thru February 4, 2017 2017 ACP Colorado Chapter Meeting – February 2, 2017 thru February 4, 2017 – Broadmoor Hotel – Colorado Springs, Colorado Name: Angela Burgin, MD Presentation Type: Oral Presentation Residency Program: University of Colorado School of Medicine Additional Authors: Winthrop Lockwood MS3, Katarzyna Mastalerz, MD Abstract Title: Use Clean Needles, Boil you Cotton: Advice for the Modern Drug User Abstract Information: Introduction: Fever in an intravenous drug abuser results in a wide differential diagnosis for the physician to consider, ranging from simple soft tissue infections to endocarditis or epidural abscess. This large breadth of possibilities often leads to dilemmas on which studies to order first, usually resulting in an expensive evaluation. We present one more option to add to the differential diagnosis in an IV drug user who presents with fever, with the hopes of increasing awareness of this condition to the medical community. Case Description: A 31 year old female with a history significant for IV drug abuse presented with dyspnea, chest pain, severe abdominal pain, right arm swelling, and generalized weakness for several days. She worked for a home health company and admitted to recently injecting hydromorphone and other opiates into her veins. Physical exam on admission was notable for a high fever, tachycardia, and right forearm edema, erythema, and induration, with a benign chest and abdominal exam. Ancillary studies revealed a urine toxicology positive for opiates, methadone, and cocaine, as well as a white blood cell count of 13.
    [Show full text]
  • Tips for Managing Treatment-Related Rash and Dry Skin
    RASH Tips for Managing Treatment-Related Rash and Dry Skin Presented by Stewart B. Fleishman, MD Continuum Cancer Centers of New York: Beth Israel & St. Luke’s-Roosevelt Lindy P. Fox, MD University of California San Francisco David H. Garfield, MD University of Colorado Comprehensive Cancer Center Carol S. Viele, RN, MS University of California San Francisco Carolyn Messner, DSW CancerCare Learn about: • Effects of targeted treatments on the skin • Managing rashes and dry skin • Treating nail conditions • Your support team Help and Hope CancerCare is a national nonprofit organization that provides free support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs—including counseling and support groups, education, financial assistance, and practical help—are provided by professional oncology social workers and are completely free of charge. Founded in 1944, CancerCare provided individual help to more than 100,000 people last year and had more than 1 million unique visitors to our websites. For more information, call 1-800-813-HOPE (4673) or visit www.cancercare.org. Contacting CancerCare National Office Administration CancerCare Tel: 212-712-8400 The material presented in this patient booklet is provided for your general 275 Seventh Avenue Fax: 212-712-8495 information only. It is not intended as medical advice and should not be relied New York, NY 10001 Email: [email protected] upon as a substitute for consultations with qualified health professionals who Email: [email protected] Website: www.cancercare.org are aware of your specific situation. We encourage you to take information and Services questions back to your individual health care provider as a way of creating a Tel: 212-712-8080 dialogue and partnership about your cancer and your treatment.
    [Show full text]
  • The Cholesterol Emboli Syndrome in Atherosclerosis
    Curr Atheroscler Rep (2013) 15:315 DOI 10.1007/s11883-013-0315-y CORONARY HEART DISEASE (JA FARMER, SECTION EDITOR) The Cholesterol Emboli Syndrome in Atherosclerosis Adriana Quinones & Muhamed Saric # Springer Science+Business Media New York 2013 Abstract Cholesterol emboli syndrome is a relatively rare, artery (typically the aorta) embolize to small or medium caliber but potentially devastating, manifestation of atherosclerotic arteries, which then results in end-organ damage secondary to disease. Cholesterol emboli syndrome is characterized by either mechanical obstruction and/or inflammatory response waves of arterio-arterial embolization of cholesterol crystals [1•]. This syndrome has also been referred as atheroembolism, and atheroma debris from atherosclerotic plaques in the atheromatous embolization syndrome, cholesterol crystal em- aorta or its large branches to small or medium caliber bolization and cholesterol embolization syndrome [2]. arteries (100–200 μm in diameter) that frequently occur It is important to emphasize that CES is a separate entity after invasive arterial procedures. End-organ damage is from a more common phenomenon of another arterio- due to mechanical occlusion and inflammatory response in arterial embolization syndrome, namely arterio-arterial the destination arteries. Clinical manifestations may include thromboembolism, in which a thrombus overlying an ather- renal failure, blue toe syndrome, global neurologic deficits omatous plaque breaks loose and travels distally to occlude and a variety of gastrointestinal, ocular and constitutional large-caliber downstream arteries [3]. In arterio-arterial signs and symptoms. There is no specific therapy for cho- thromboembolism, there is typically a sudden release of lesterol emboli syndrome. Supportive measures include thrombi, resulting in acute ischemia of a target organ.
    [Show full text]
  • Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): an Up-To-Date Overview
    Dermatology Practical & Conceptual Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): An Up-to-Date Overview Enzo Errichetti1 1 Institute of Dermatology, Santa Maria della Misericordia University Hospital, Udine, Italy Key words: dermoscopy, differential diagnosis, general dermatology, inflammoscopy Citation: Errichetti E. Dermoscopy of inflammatory dermatoses (inflammoscopy): an up-to-date overview. Dermatol Pract Concept. 2019;9(3):169-180. DOI: https://doi.org/10.5826/dpc.0903a01 Accepted: June 2, 2019; Published: July 31, 2019 Copyright: ©2019 Errichetti. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: None. Competing interests: The author has no conflicts of interest to disclose. Authorship: The author takes responsibility for this publication. Corresponding author: Enzo Errichetti, MD, MSc, Institute of Dermatology, Santa Maria della Misericordia University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100 Udine, Italy. Email: [email protected] ABSTRACT In addition to its use in pigmented and nonpigmented skin tumors, dermoscopy is gaining apprecia- tion in assisting the diagnosis of nonneoplastic diseases, especially inflammatory dermatoses (inflam- moscopy). In this field, dermoscopic examination should be considered as the second step of a “2-step procedure,” always preceded by the establishment of a differential diagnosis on the basis of clinical examination. In this paper, we sought to provide an up-to-date overview on the use of dermoscopy in common inflammatory dermatoses based on the available literature data. For practical purposes, the analyzed dermatoses are grouped according to the clinical presentation pattern, in line with the 2-step procedure principle: erythematous-desquamative and papulosquamous dermatoses, papulokeratotic dermatoses, erythematous facial dermatoses, sclero-atrophic dermatoses, and miscellaneous.
    [Show full text]
  • Review Skin Changes Are One of the Earliest Signs of Venous a R T I C L E Hypertension
    pp 11 - 19 ABSTRACT Review Skin changes are one of the earliest signs of venous A R T I C L E hypertension. Some of these changes such as venous eczema are common and easily identified whereas DERMATOLOGICAL other changes such as acroangiodermatitis are less common and more difficult to diagnose. Other vein MANIFESTATIONS OF VENOUS related and vascular disorders can also present with specific skin signs. Correct identification of these DISEASE: PART I skin changes can aid in making the right diagnosis and an appropriate plan of management. Given KUROSH PARSI, MBBS, MSc(Med), FACD, FACP the significant overlap between phlebology and Departments of Dermatology, St. Vincent’s Hospital and dermatology, it is essential for phlebologists to be Sydney Children’s Hospital familiar with skin manifestations of venous disease. Sydney Skin & Vein Clinic, This paper is the first installment in a series of 3 Bondi Junction, NSW, Australia and discusses the dermatological manifestations of venous insufficiency as well as other forms of vascular ectasias that may present in a similar Introduction fashion to venous incompetence. atients with venous disease often exhibit dermatological Pchanges. Sometimes these skin changes are the only clue to an appropriate list of differential diagnoses. Venous ulceration. Less common manifestations include pigmented insufficiency is the most common venous disease which purpuric dermatoses, and acroangiodermatitis. Superficial presents with a range of skin changes. Most people are thrombophlebitis (STP) can also occur in association with familiar with venous eczema, lipodermatosclerosis and venous incompetence but will be discussed in the second venous ulcers as manifestations of long-term venous instalment of this paper (Figure 2).
    [Show full text]
  • Unprotected Carotid Artery Stenting in Symptomatic Patients with High-Grade Stenosis: Results and Long-Term Follow-Up in a Single- ORIGINAL RESEARCH Center Experience
    Published March 15, 2012 as 10.3174/ajnr.A2951 Unprotected Carotid Artery Stenting in Symptomatic Patients with High-Grade Stenosis: Results and Long-Term Follow-Up in a Single- ORIGINAL RESEARCH Center Experience R. Oteros BACKGROUND AND PURPOSE: The use of cerebral protection during CAS is an extended practice. E. Jimenez-Gomez Paradoxically it is open to question because it can lead to potential embolic complications. The aim of this study was to evaluate the safety and efficacy of CASWPD in patients with severe symptomatic F. Bravo-Rodriguez carotid artery stenosis. J.J. Ochoa R. Guerrero MATERIALS AND METHODS: A prospective study was performed including 210 consecutive patients (201 symptomatic and 9 asymptomatic) with carotid artery stenosis Ͼ70%. All patients were treated F. Delgado by CASWPD. Angiographic results and neurologic complications were recorded during the procedure and within 30 days after it. All patients underwent clinical evaluation and Doppler sonography follow-up at 3, 6, and 12 months after the procedure. RESULTS: Two hundred twenty carotid arteries were treated. The average degree of stenosis was 88.9%. The procedure was successfully completed in 212 (96.4%) arteries. After stent placement, 98.6% of arteries showed no residual stenosis or Ͻ30%. Balloon angioplasty dilation before stent placement was performed in 16% of cases. During the 30-day periprocedural period, there were 3 major complications (1.4%), including 1 disabling ischemic stroke, 1 acute stent thrombosis, and 1 MI. The last 2 patients died from these complications. At 1-year follow-up 24 (12.8%) restenoses, 2 new ipsilateral strokes, 1 contralateral stroke, and 5 deaths (2.7%) had occurred.
    [Show full text]
  • Progressive Widespread Warty Skin Growths
    DERMATOPATHOLOGY DIAGNOSIS Progressive Widespread Warty Skin Growths Patrick M. Kupiec, BS; Eric W. Hossler, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis article in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumu- lating multiple credits. A 33-year-old man presented with progres- sive widespread warty skin growths that had been present copysince 6 years of age. Physical examination revealed numerous verrucous papules on the face and neck along with Figure 1. H&E, original magnification ×40. Figure 2. H&E, original magnification ×40. verrucous, tan-pink papules and plaques diffuselynot scattered on the trunk, arms, and legs. A biopsy of a lesion on the neck Dowas performed. H&E, original magnification ×200. The best diagnosisCUTIS is: a. condyloma acuminatum b. epidermodysplasia verruciformis c. herpesvirus infection d. molluscum contagiosum e. verruca vulgaris PLEASE TURN TO PAGE 99 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Mr. Kupiec is from the State University of New York (SUNY) Upstate Medical University, Syracuse. Dr. Hossler is from the Departments of Dermatology and Pathology, Geisinger Medical Center, Danville, Pennsylvania. The authors report no conflict of interest. Correspondence: Patrick M. Kupiec, BS, 50 Presidential Plaza, Syracuse, NY 13202 ([email protected]). 82 CUTIS® WWW.CUTIS.COM Copyright Cutis 2017. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher.
    [Show full text]
  • Vulvar Disease: Overview of Diagnosis and Management for College Aged Women
    Vulvar Disease: Overview of Diagnosis and Management for College Aged Women Lynette J. Margesson MD FRCPC ACHA 2013 Annual Meeting, May 30, 2013 No Conflicts of interest Lynette Margesson MD Little evidence based treatment Most information is from small open trials and clinical experience. Most treatment discussed is “off-label” Why Do Vulvar Disease ? Not taught Not a priority Takes Time Still an area if taboo VULVAR CARE IS COMMONLY UNAVAILABLE For women this is devastating Results of Poor Vulvar Care Women : - suffer with undiagnosed symptoms - waste millions of dollars on anti-yeasts - hide and scratch - endure vulvar pain and dyspareunia - are desperate for help VULVA ! What is that? Down there? Vulvar Education Lets eliminate the “Down there” generation Use diagrams and handouts See www.issvd.org - patient education Recognize Normal Anatomy Normal vulvar anatomy Age Race Hormones determine structure - Size & shape - Pigmentation -Hair growth History A good,detailed,accurate history All previous treatment Response to treatment All medications, prescribed and over-the-counter TAKE TIME TO LISTEN Genital History in Women Limited by: embarrassment lack of knowledge social taboos Examination Tips Proper visualization - light + magnification Proper lighting – bright, but no glare Erythema can be normal Examine rest of skin, e.g. mouth, scalp and nails Many vulvar diseases scar, not just lichen sclerosus Special Anatomic Variations Sebaceous hyperplasia ectopic sebaceous glands Vulvar papillomatosis Pre-anesthesia – BIOPSY use a topical
    [Show full text]